Efficacy and safety of Bruton's tyrosine kinase inhibitors in the treatment of pemphigus: A comprehensive literature review and future perspective
Author:
Ghane YektaORCID,
Heidari Nazila,
Heidari Amirhossein,
Sadeghi SaraORCID,
Goodarzi AzadehORCID
Subject
Multidisciplinary
Reference26 articles.
1. Pemphigus: current and future therapeutic strategies;Didona;Front. Immunol.,2019
2. Comprehensive review on the pathophysiology, clinical variants and management of pemphigus (review);Costan;Exp. Ther. Med.,2021
3. Bruton tyrosine kinase inhibition warrants further study for pemphigus;Drucker;Br. J. Dermatol.,2021
4. A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigus;Yamagami;J. Dermatol. Sci.,2021
5. Tofacitinib as the potent treatment for refractory pemphigus: a possible alternative treatment for pemphigus;Tavakolpour;Dermatol. Ther.,2018